Clomiphene vs Sitagliptin: side-by-side comparison
Clomiphene (Selective estrogen receptor modulator (ovulation induction)) and Sitagliptin (DPP-4 inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Clomiphene | Sitagliptin |
|---|---|---|
| Therapeutic class | Selective estrogen receptor modulator (ovulation induction) | DPP-4 inhibitor |
| CAS | 911-45-5 | 486460-32-6 |
| ATC | G03GB02 | A10BH01 |
| Molecular weight | 405.96 g/mol | 407.31 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Clomiphene and Sitagliptin share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Clomiphene acts by a different mechanism than Sitagliptin, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Clomiphene: Le clomifène agit comme antagoniste compétitif des récepteurs des estrogènes au niveau de l'hypothalamus, bloquant le rétrocontrôle négatif normalement exercé par les estrogènes sur la production hypothalamique de gonado… Sitagliptin: La sitagliptine inhibe de façon réversible la DPP-4, sérine protéase responsable de la dégradation rapide du glucagon-like peptide 1 (GLP-1) et du polypeptide insulinotrope glucose-dépendant (GIP).
Indications compared
Clomiphene: Le clomifène est autorisé dans le traitement de l'infertilité anovulatoire chez les femmes dont la fonction hypophyso-ovarienne est intacte — en particulier en cas de syndrome des ovaires polykystiques — lorsque les autr… Sitagliptin: La sitagliptine est autorisée chez l'adulte atteint de diabète de type 2, seule ou en association à d'autres antidiabétiques, pour améliorer le contrôle glycémique.
Safety profile
Clomiphene: Les effets indésirables fréquents comprennent bouffées de chaleur, variations de l'humeur, tension mammaire, augmentation du volume ovarien et troubles visuels (habituellement réversibles à l'arrêt). Sitagliptin: La sitagliptine est généralement bien tolérée.
Questions fréquentes
Is Clomiphene better than Sitagliptin? ▾
Clomiphene and Sitagliptin are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Clomiphene and Sitagliptin be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Clomiphene
Products with Sitagliptin
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.